Neonatal Intra-Abdominal Mixed Germ Cell Tumour with Retroperitoneal Extension Mimicking Hepatoblastoma: A Diagnostic Challenge - A Case Report.
This case report describes a 2-month-old infant with a malignant intra-abdominal mixed germ cell tumour initially suspected to be hepatoblastoma who remained disease free at 3 years after resection and adjuvant bleomycin, carboplatin, and etoposide chemotherapy.
Open original publication →What the AI sees
This case report describes a 2-month-old infant with a malignant intra-abdominal mixed germ cell tumour initially suspected to be hepatoblastoma who remained disease free at 3 years after resection and adjuvant bleomycin, carboplatin, and etoposide chemotherapy.
Research significance
The reported outcome provides limited evidence that surgery followed by platinum-based combination chemotherapy can achieve durable disease control in this rare presentation; it is only an inference—not established by this single case—that this approach is broadly effective or optimal for neonatal intra-abdominal mixed germ cell tumours.
Source abstract
INTRODUCTION: Neonatal germ cell tumours (GCTs) are rare, and intra-abdominal mixed GCTs are even less common. Although most solid tumours in neonates are benign, malignant cases occur at an estimated rate of 1 in 27,500 live births, accounting for about 2% of all childhood cancers. Differentiating benign from malignant neonatal neoplasms is a significant diagnostic challenge due to overlapping clinical and radiological features. We report one of the few documented cases of an intra-abdominal mixed GCT in an Indian neonate, highlighting the importance of early recognition and a multidisciplinary management approach. CASE PRESENTATION: A 2-month-old male infant presented with progressive abdominal distension and constipation since the 15th day of life. Abdominal examination revealed a firm, non-mobile, irregular mass measuring 10 × 8 cm in the upper abdomen. Imaging studies identified a large intra-abdominal mass with retroperitoneal extension initially suspected to represent hepatoblastoma. Intraoperative findings revealed a 12 × 10 cm tumour adherent to the left lobe of the liver and extending into the retroperitoneum. Histopathological examination confirmed a malignant mixed GCT comprising yolk sac and teratomatous elements. The patient underwent left lateral segmentectomy followed by adjuvant bleomycin, carboplatin, and etoposide chemotherapy. He remains disease free at 3-year follow-up, with normalised serum alpha-fetoprotein (AFP) levels and no evidence of recurrence on magnetic resonance imaging. CONCLUSION: This case illustrates the diagnostic complexity and surgical challenges inherent to neonatal intra-abdominal mixed GCTs with retroperitoneal extensions. The atypical location and initial radiological misdiagnosis highlight the necessity of comprehensive tumour marker evaluation, advanced imaging, and multidisciplinary collaboration for accurate diagnosis and optimal management. Early recognition, multidisciplinary evaluation, and timely intervention facilitated successful management in the present case. However, longer follow-up and additional reports are required to characterise outcomes in this rare neonatal tumour better.